SenzaGen (Sweden) Today
| SENZA Stock | SEK 6.95 0.10 1.42% |
Performance0 of 100
| Odds Of DistressOver 67
|
SenzaGen is selling for under 6.95 as of the 2nd of December 2024; that is 1.42 percent decrease since the beginning of the trading day. The stock's lowest day price was 6.85. SenzaGen has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for SenzaGen AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of November 2024 and ending today, the 2nd of December 2024. Click here to learn more.
SenzaGen AB, together with its subsidiary, markets, sells, and performs in vitro genomic allergen rapid detection sensitization tests for the screening of pharmaceutical candidates, and safety assessment of chemicals and cosmetic ingredients in Sweden and internationally. The company has 24.19 M outstanding shares. More on SenzaGen AB
Moving together with SenzaGen Stock
Moving against SenzaGen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
SenzaGen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. SenzaGen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding SenzaGen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
SenzaGen AB (SENZA) is traded on Stockholm Exchange in Sweden and employs 29 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 308.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SenzaGen's market, we take the total number of its shares issued and multiply it by SenzaGen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. SenzaGen AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 24.19 M outstanding shares.
SenzaGen AB has accumulated about 69.16 M in cash with (20.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.63.
Check SenzaGen Probability Of Bankruptcy
Ownership AllocationSenzaGen AB shows a total of 24.19 Million outstanding shares. SenzaGen AB maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check SenzaGen Ownership Details
SenzaGen AB Risk Profiles
Although SenzaGen's alpha and beta are two of the key measurements used to evaluate SenzaGen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.85 | |||
| Standard Deviation | 2.37 | |||
| Variance | 5.62 | |||
| Risk Adjusted Performance | (0.03) |
SenzaGen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in SenzaGen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
SenzaGen Corporate Management
Elected by the shareholders, the SenzaGen's board of directors comprises two types of representatives: SenzaGen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SenzaGen. The board's role is to monitor SenzaGen's management team and ensure that shareholders' interests are well served. SenzaGen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SenzaGen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marisa Meloni | Founder Srl | Profile | |
| Anna Hansson | Chief Commercial Officer | Profile | |
| Helen Olsson | VP HR | Profile | |
| Asa Nyhlen | VP Operations | Profile | |
| Henrik Johansson | Chief Scientist | Profile |
Additional Tools for SenzaGen Stock Analysis
When running SenzaGen's price analysis, check to measure SenzaGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenzaGen is operating at the current time. Most of SenzaGen's value examination focuses on studying past and present price action to predict the probability of SenzaGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenzaGen's price. Additionally, you may evaluate how the addition of SenzaGen to your portfolios can decrease your overall portfolio volatility.